Shuttle Pharmaceuticals (SHPH) Stock Analysis
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
What Shuttle Pharmaceuticals does
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Key metrics
ETFs linked to SHPH
Broad-market and Healthcare sector ETFs an investor holding Shuttle Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how SHPH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze SHPH in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Shuttle Pharmaceuticals?
- Shuttle Pharmaceuticals trades under the ticker SHPH on NASDAQ.
- Which exchange is SHPH listed on?
- SHPH is listed on NASDAQ.
- What sector does Shuttle Pharmaceuticals operate in?
- Shuttle Pharmaceuticals is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
- How can PortView help analyze SHPH in a portfolio?
- PortView shows SHPH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.